Latest filing published 14 May 2008 for CYTOGENIX INC, €6,335.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Malcolm Skolnick: trading record in brief
This profile gathers the share dealings of Malcolm Skolnick in Cytogenix Inc. We count 6 filings; the first trade dates from 5 October 2007 and the latest from 14 April 2008.
Purchases make up the whole of the open-market record (6 purchases, €28k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2008, the count stands at 1 purchase and no sales.
The median purchase comes to €4,247.
The newest entry dates from 14 May 2008: an open-market purchase of €6,335, in Cytogenix Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Malcolm Skolnick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 166,667 shares@ US$0.06CytoGenix, Inc. Common StockSEC:0001121781-08-000226:0Canonical exit: 13 Jul 2008 (T+90)
- 15,000 shares@ US$0.25CytoGenix, Inc. Common StockSEC:0001121781-07-000378:0Canonical exit: 25 Feb 2008 (T+90)
- 30,000 shares@ US$0.25CytoGenix, Inc. Common StockSEC:0001121781-07-000370:0Canonical exit: 13 Feb 2008 (T+90)
- 20,000 shares@ US$0.25CytoGenix, Inc. Common StockSEC:0001121781-07-000371:0Canonical exit: 19 Feb 2008 (T+90)
- 15,000 shares@ US$0.28Common StockSEC:0001121781-07-000311:0Canonical exit: 3 Jan 2008 (T+90)
- 35,000 shares@ US$0.29Common StockSEC:0001121781-07-000311:1Canonical exit: 3 Jan 2008 (T+90)
6 of 6 declarations